Long-term effects of transcranial direct current stimulation in the treatment of autism spectrum disorder: A

Paradee Auvichayapat1,2, Krittiya Intayot1,2, Chavisa Udomchat3

  • 1Noninvasive Brain Stimulation Research Group of Thailand, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Insights

Five sessions of transcranial direct current stimulation (tDCS) effectively reduced autism severity in children, with benefits lasting over a year. Twenty sessions showed no additional advantage over five sessions for autism symptom reduction.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Clinical Psychology

Background:

  • Autism spectrum disorder (ASD) presents significant challenges in social communication and behavior.
  • Current interventions for ASD vary in efficacy and accessibility.
  • Non-invasive brain stimulation techniques like tDCS are being explored as potential therapeutic options for ASD.

Purpose of the Study:

  • To compare the effectiveness of 0, 5, and 20 sessions of transcranial direct current stimulation (tDCS) in reducing autism spectrum disorder (ASD) symptoms.
  • To determine if a higher number of tDCS sessions offers superior outcomes compared to a lower number or sham treatment.

Main Methods:

  • Thirty-six male children diagnosed with ASD were stratified and assigned to three groups: 20 sessions of sham tDCS (control), 5 active tDCS sessions followed by 15 sham sessions (5-tDCS), or 20 active tDCS sessions (20-tDCS).
  • All participants engaged in special school activities.
  • Autism severity was assessed using the Childhood Autism Severity Scale (CARS) as the primary outcome measure.

Main Results:

  • Both the 5-tDCS and 20-tDCS groups showed significantly greater reductions in autism severity compared to the control group at multiple time points (days 5 and 14, months 6 and 12).
  • No significant differences in symptom reduction were observed between the 5-tDCS and 20-tDCS groups.
  • Clinically meaningful improvements were noted starting on day 5 for active tDCS groups and month 6 for the control group, with benefits sustained up to 12 months.

Conclusions:

  • Five sessions of active tDCS appear to be as effective as 20 sessions in reducing ASD symptoms.
  • Active tDCS treatment led to faster symptom improvement compared to sham treatment.
  • The positive effects of tDCS on autism severity were maintained for at least one year.
Abstract

Related Concept Videos